IG/HY Healthcare: Readying for Pharma Tariffs

US Autos: Tariff Recommendation Rerack

European 2Q25 Outlook Update: Stuck in the Middle

U.S. Liability Management Transactions: Quarterly Update Through Q1 2025

Post-Liberation Day Scoreboard: Tactical OW HY

US Hotels & Gaming: Weighing Tariff Ripple Effects

Asia Strategy: Tariff Risks By Market

Tariffs: Aerospace & Defense Impact

EMEA Special Situations: French distressed activity on the increase as insolvency laws drive more mid-market processes

US Inv. Grade Favorite A-Rated Names

US Insurance: Tariff Impact Risk Spectrum

Tariffs: US IG Chem Sector Winners/Losers

Euro Strategy: Tariff Risks by Sector

US Tariff Insights

US Post Petition: Bankruptcy Advisor Leaderboard – Q1’25

Trends in Chems: Trump and Tariffs

US Retail: Tariff Thoughts for US Apparel/Footwear

Technology: Reciprocal Tarrifs Impact

APAC Banks: A Review/Forecast of Basel 4 Impact

Mar ’25 FOMC: Exceptionalism to Stagflation(ism)

Bausch Health: Initial Impressions on the Refinancing Transactions

BHC: Jumbo Refinancing Transaction

Global Autos: US Import Tariff Implications

US Strategy: Tariff Risks by Sector

Bausch Health: Initial Impressions on the New Proposals

Cemex Spotlight – Tariffs, Hybrids and New CEO

Synopsys: 6-Pt Benchmark Issuance for Ansys Deal

US Macro: Updated Duration Thoughts

Liberty Global 4Q24: Yet Another Transition Year

Strategy: Tracking Tech’s Tectonic Transformation

INTC: Nearing Foundry Deal w/ TSMC at the Table?

Euro Real Estate: German Election Considerations